Research trials of psychedelic drugs were truncated by the politics of the 1960s. Dr Lieberman explains why we need to begin studying them again, before public opinion gets ahead of what we know.
Experts take on the issue of value in cancer care -- among the hottest topics of ASCO 2015 -- and what is at stake if efforts to ensure value do not succeed in containing healthcare costs.
Dr Yellowlees discusses findings of a Cochrane Review that checks the value of the Mini-Mental State Examination for predicting which patients will advance to dementia.